Brief: Angion Provides Q2 2022 Financial Results

Elicio Therapeutics

15/08/2022 21:58

Aug 15 (Reuters) - Angion Biomedica Corp  ANGN.O :
    * ANGION PROVIDES CORPORATE UPDATE AND REPORTS SECOND
QUARTER 2022
FINANCIAL RESULTS
    * ANGION BIOMEDICA CORP - AS OF JUNE 30, 2022, CO HAD CASH
AND
CASH EQUIVALENTS TOTALING $63.4 MILLION
    * ANGION - SEES CURRENT CASH RESOURCES SUFFICIENT TO FUND
PROJECTED OPERATING REQUIREMENTS FOR 12 MONTHS AFTER ISSUANCE
DATE OF FINANCIAL STATEMENTS
    * ANGION BIOMEDICA CORP - QTRLY LOSS PER SHARE $0.30

Source text for Eikon:  ID:nGNXtF3HQ 
Further company coverage:  ANGN.O 

 ((Reuters.Briefs@thomsonreuters.com;))